| Net Cash Provided by (Used in) Operating Activities |
$291,268,000 |
USD |
-46% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$62,128,000 |
USD |
-907% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$186,645,000 |
USD |
6.6% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
120,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
72,224,593 |
shares |
0.62% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
1 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$42,506,000 |
USD |
-88% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$355,627,000 |
USD |
-41% |
Q2 2025 |
Q2 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$69,975,000 |
USD |
7.2% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$0 |
USD |
-100% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$7,000,000 |
USD |
|
Q2 2025 |
Q2 2025 |
| Payments to Acquire Property, Plant, and Equipment |
$187,496,000 |
USD |
-15% |
Q1 2025 |
Q1 2025 |
| Comprehensive Income (Loss), Net of Tax, Attributable to Parent |
$448,545,000 |
USD |
133% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$146,287,000 |
USD |
1.5% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$591,000 |
USD |
-24% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Net of Valuation Allowance |
$228,961,000 |
USD |
0.88% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$286,557,000 |
USD |
5.5% |
Q1 2024 |
Q1 2024 |